Skip to content

Author

Yan-Long Wang

We have 2 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Disruption of the AR/ZNF217/PROM2 axis sensitizes prostate cancer to ferroptosis and enzalutamide therapy

These findings identify AR/ZNF217/PROM2 signaling as a central determinant of ferroptotic vulnerability in prostate cancer and suggest that targeting this pathway may enhance sensitivity to AR inhibition, providing a molecular rationale for combination therapy in castration-resistant prostate cancer.

Wenjun Hao, Peng Liang, Wanglong Zheng et al. · 0 citations
Case report Open access Jul 2026

Compound heterozygous variants in PATL2 cause oocyte germinal vesicle arrest associated with primary infertility: a case report and literature review

GV arrest caused by PATL2 defects cannot be overcome by conventional or optimized IVF protocols even with individualized COH, and Donor-oocyte IVF remains the ultimate effective strategy for pregnancy in such patients.

Xiaoxia Song, Lei Yan, Yiwen Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.